Literature DB >> 941118

Cardiovascular depressant effect of protamine sulphate: experimental study and clinical implications.

M A Fadali, C A Papacostas, J J Duke, M Ledbetter, M Osbakken.   

Abstract

The mechanisms underlying protamine-induced hypotension and bradycardia were the subject of this investigation. Six groups of dogs with intact circulation were tested in controlled circumstances with various drugs. The following parameters were observed: femoral arterial pressure, central venous pressure, left ventricular pressure and its rate of rise, left ventricular contractile element velocity of shortening, maximal Vce, and cardiac output. The six groups were studied under these pharmacological conditions: ganglionic and adrenal medullary block with hexamethonium chlroide, postganglionic parasympathetic blockade by atropine sulphate, alpha and beta adrenergic receptor block by phenoxybenzamine and propranolol respectively, and depletion of endogenous histamine by compound 48/80 (a condensation product of p-methoxyphenethyl methylamine with formaldehyde). The last group was put on extracorporeal circulation to isolate the vascular tree from the heart. The effect of the drug on this isolated vasculature was observed by recording the femoral arterial pressure. Our findings show that the hypotension and bradycardia are produced by a direct effect of protamine on the myocardium and peripheral vascular system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941118      PMCID: PMC470432          DOI: 10.1136/thx.31.3.320

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  EFFECT OF PROTAMINE SULPHATE ON THE TRANSMISSION PROCESSES IN PERIPHERAL SYMPATHETIC GANGLIA.

Authors:  E MINKER; M KOLTAI
Journal:  Acta Physiol Acad Sci Hung       Date:  1964

2.  The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine.

Authors:  W S EGERTON; C L ROBINSON
Journal:  Lancet       Date:  1961-09-16       Impact factor: 79.321

3.  Studies on the toxicology of a histamine liberator, compound 48-80.

Authors:  C A PAPACOSTAS; E R LOEW; G B WEST
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-07-01

4.  The neutralization of heparin by protamine in extracorporeal circulation.

Authors:  F GERBODE; R HURT; J J OSBORN; H A PERKINS
Journal:  J Thorac Surg       Date:  1956-11

5.  Compound 48/80: a potent histamine liberator.

Authors:  W D M PATON
Journal:  Br J Pharmacol Chemother       Date:  1951-09

6.  Quantification of the contractile state of the intact human heart. Maximal velocity of contractile element shortening determined by the instantaneous relation between the rate of pressure rise and pressure in the left ventricle during isovolumic systole.

Authors:  D T Mason; J F Spann; R Zelis
Journal:  Am J Cardiol       Date:  1970-09       Impact factor: 2.778

7.  Cardiovascular effects of protamine sulfate.

Authors:  B S Goldman; J Joison; W G Austen
Journal:  Ann Thorac Surg       Date:  1969-05       Impact factor: 4.330

8.  Protamine sulfate administration and the cardiovascular system.

Authors:  A Gourin; R L Streisand; J K Greineder; J H Stuckey
Journal:  J Thorac Cardiovasc Surg       Date:  1971-08       Impact factor: 5.209

  8 in total
  3 in total

1.  Haemodynamic changes and circulating histamine concentrations following protamine administration to patients and dogs.

Authors:  R K Stoelting; D P Henry; K M Verburg; R L McCammon; R D King; J W Brown
Journal:  Can Anaesth Soc J       Date:  1984-09

2.  The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.

Authors:  B Milne; K Rogers; F Cervenko; T Salerno
Journal:  Can Anaesth Soc J       Date:  1983-07

3.  Effect of protamine on plasma ionized calcium in the dog.

Authors:  R M Jones; A B Hill; M L Nahrwold; A R Tait
Journal:  Can Anaesth Soc J       Date:  1982-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.